: T2 Biosystems stock surges more than 14% premarket to continue rally


Shares of micro cap T2 Biosystems Inc. TTOO rose 14.3% in premarket trades Tuesday, continuing a rally that saw the stock end Monday’s session up 15.4%. The stock is on a two-day winning streak after ending Friday’s session up 3.3%. T2 has been generating meme-like buzz recently and its stock has risen 323.9% in the last month. The company, which describes itself as a leader in the rapid detection of sepsis-causing pathogens and antibiotic-resistance genes, has a market cap of $112.72 million. Last week Alliance Global Partners raised its T2 price target to 18 cents from 7 cents following the company’s second-quarter…

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleMarket Snapshot: U.S. stock futures slide as China growth angst rattles global risk appetite
Next articleHome Depot announces $15 billion stock buyback as same-store sales slip 2%


Please enter your comment!
Please enter your name here